Cardiovascular adverse events in chronic myeloid leukemia patients treated with nilotinib or imatinib: A systematic review, meta-analysis and integrative bioinformatics analysis

OBJECTIVE: The aim of this article is to assess the risk and potential mechanisms of cardiovascular adverse events in patients treated with nilotinib or imatinib by conducting a systematic review, meta-analysis and integrative bioinformatics analysis. MATERIALS AND METHODS: Three databases were syst...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Sicong, He, Jinshan, Zhang, Xinyi, Cai, Yuchun, Liu, Jian, Nie, Xiaoyan, Shi, Luwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678945/
https://www.ncbi.nlm.nih.gov/pubmed/36426222
http://dx.doi.org/10.3389/fcvm.2022.966182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678945/
https://www.ncbi.nlm.nih.gov/pubmed/36426222
http://dx.doi.org/10.3389/fcvm.2022.966182

Ejemplares similares